Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis.
about
Bactericidal activity of PA-824 against Mycobacterium tuberculosis under anaerobic conditions and computational analysis of its novel analogues against mutant Ddn receptorUpdate in tuberculosis 2006.Micro- and nanocarrier-mediated lung targeting.State of the art and future directions in nanomedicine for tuberculosis.Concise assembly of linear alpha(1-->6)-linked octamannan fluorescent probe.Application of a four-fluid nozzle spray drier to prepare inhalable rifampicin-containing mannitol microparticles.
P2860
Novel conjugate of moxifloxacin and carboxymethylated glucan with enhanced activity against Mycobacterium tuberculosis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Novel conjugate of moxifloxaci ...... st Mycobacterium tuberculosis.
@en
type
label
Novel conjugate of moxifloxaci ...... st Mycobacterium tuberculosis.
@en
prefLabel
Novel conjugate of moxifloxaci ...... st Mycobacterium tuberculosis.
@en
P2093
P2860
P356
P1476
Novel conjugate of moxifloxaci ...... st Mycobacterium tuberculosis.
@en
P2093
A M Shestapalov
A P Agafonov
A V Svistelnik
A Y Alekseev
D V Saraev
E V Melnikova
M I Dushkin
O M Khoschenko
P2860
P304
P356
10.1128/AAC.00362-05
P407
P577
2006-06-01T00:00:00Z